Save your place

Sign in to WhoBought

Please try again later.

Candel Therapeutics, Inc. (CADL) institutional ownership

Latest close $10.01 Jul 31, 2026
Market cap$335M 52-week range SectorHealthcare
Funds holding · Q1 2026
105
reported CADL position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
75 buyers · 30 sellers

Candel Therapeutics, Inc. (CADL) price and institutional activity

Dates

Q1 2026

$0 bought by 75 investors
Rtw Investments, LPSaturn V Capital Management LP +73 more
$0 sold by 30 investors
Citadel Advisors LLCFocus Partners Wealth +28 more
Bought Sold Totals per quarter; hover a bar for the names.

Candel Therapeutics, Inc. (CADL) institutional activity · 30

Investor Type Est. change Change Δ Own Date
Citadel Advisors LLC Reduced· Q1 2026 −154K −67.9% Q1 2026
Focus Partners Wealth · Exited
Change −82K Δ Own −100.0% Date Q1 2026
Focus Partners Wealth Exited· Q1 2026 −82K −100.0% Q1 2026
Morgan Stanley · Reduced
Change −76K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −76K Q1 2026
Barclays PLC · Reduced
Change −58K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −58K Q1 2026
Wells Fargo & Company · Reduced
Change −57K Date Q1 2026
Wells Fargo & Company Reduced· Q1 2026 −57K Q1 2026
State of Wisconsin Investment Board · Exited
Change −52K Δ Own −100.0% Date Q1 2026
State of Wisconsin Investment Board Exited· Q1 2026 −52K −100.0% Q1 2026
Virtu Financial LLC · Exited
Change −27K Δ Own −100.0% Date Q1 2026
Virtu Financial LLC Exited· Q1 2026 −27K −100.0% Q1 2026
Susquehanna International Group, LLP · Reduced
Change −24K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −24K Q1 2026
Squarepoint Ops LLC · Exited
Change −20K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −20K −100.0% Q1 2026
Alphaquest LLC · Exited
Change −12K Δ Own −100.0% Date Q1 2026
Alphaquest LLC Exited· Q1 2026 −12K −100.0% Q1 2026
Jane Street Group, LLC · Exited
Change −11K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −11K −100.0% Q1 2026
Proshare Advisors LLC · Exited
Change −10K Δ Own −100.0% Date Q1 2026
Proshare Advisors LLC Exited· Q1 2026 −10K −100.0% Q1 2026
Schwab · Reduced
Change −9K Date Q1 2026
Schwab Reduced· Q1 2026 −9K Q1 2026
Intech Investment Management LLC · Reduced
Change −6K Date Q1 2026
Intech Investment Management LLC Reduced· Q1 2026 −6K Q1 2026
Two Sigma Investments, LP · Reduced
Change −6K Δ Own −5.7% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −6K −5.7% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 30

Famous investor activity in Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc. (CADL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Sims Mark E. · Officer Grant (A) 285K
Owned 285K Trade date Jul 6, 2026 Filed date Jul 8, 2026
Sims Mark E. Officer Grant (A) 285K 285K Jul 6, 2026 Jul 8, 2026
Manning Paul B. · Director Grant (A) $19K
Price $8.64 Qty 2K Owned 2K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Manning Paul B. Director Grant (A) $8.64 2K $19K 2K Jun 30, 2026 Jul 1, 2026
Papa Joseph C. · Director Grant (A) $11K
Price $8.64 Qty 1K Owned 1K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Papa Joseph C. Director Grant (A) $8.64 1K $11K 1K Jun 30, 2026 Jul 1, 2026
Loggia Nicoletta · Director Grant (A) $3K
Price $8.64 Qty 381 Owned 381 Trade date Jun 30, 2026 Filed date Jul 1, 2026
Loggia Nicoletta Director Grant (A) $8.64 381 $3K 381 Jun 30, 2026 Jul 1, 2026
Barone Francesca · Officer Sell −$236K
Price $10.06 Qty −23K Owned 77K ΔOwn −23.3% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Barone Francesca Officer Sell $10.06 −23K −$236K 77K −23.3% Jun 29, 2026 Jul 1, 2026
Tyagarajan Seshu · Officer Sell −$70K
Price $10.02 Qty −7K Owned 84K ΔOwn −7.7% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Tyagarajan Seshu Officer Sell $10.02 −7K −$70K 84K −7.7% Jun 29, 2026 Jul 1, 2026
Radhakrishnan Maha · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Radhakrishnan Maha Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Loggia Nicoletta · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Loggia Nicoletta Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Papa Joseph C. · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Papa Joseph C. Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Benz Edward J. Jr · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Benz Edward J. Jr Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Martell Christopher · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Martell Christopher Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Gaeta Renee · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Gaeta Renee Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Nabel Gary J. · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Nabel Gary J. Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Nguyen Diem · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Nguyen Diem Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
Manning Paul B. · Director Grant (A) 32K
Owned 32K Trade date Jun 23, 2026 Filed date Jun 24, 2026
Manning Paul B. Director Grant (A) 32K 32K Jun 23, 2026 Jun 24, 2026
15 of 24
15 of 24 Sign in to continue to older insider transactions.

Candel Therapeutics, Inc. (CADL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Manning Paul B 4.1M
% of shares outstanding 13.6% Filing date Feb 14, 2022
Manning Paul B 4.1M 13.6% Feb 14, 2022
Rtw Investments, LP 6.4M
% of shares outstanding 8.8% Filing date May 15, 2026
Rtw Investments, LP 6.4M 8.8% May 15, 2026
Blackrock, Inc. 4.8M
% of shares outstanding 6.6% Filing date Jul 27, 2026
Blackrock, Inc. 4.8M 6.6% Jul 27, 2026
Northpond Ventures, LP 1.7M
% of shares outstanding 5.9% Filing date Feb 14, 2022
Northpond Ventures, LP 1.7M 5.9% Feb 14, 2022
Cvi Investments, Inc. 2.4M
% of shares outstanding 5.6% Filing date Dec 17, 2024
Cvi Investments, Inc. 2.4M 5.6% Dec 17, 2024
Blackrock, Inc. 3.1M
% of shares outstanding 4.2% Filing date Apr 27, 2026
Blackrock, Inc. 3.1M 4.2% Apr 27, 2026
FMR LLC 738K
% of shares outstanding 2.6% Filing date Feb 9, 2023
FMR LLC 738K 2.6% Feb 9, 2023
7 of 7

Candel Therapeutics, Inc. (CADL) ownership FAQ

Who owns CADL?

105 reporting institutions disclosed CADL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.